Clinical immunosuppression, lymphocyte subsets, and host defense mechanisms.
Guttmann
R D
RD
McGill University Centre for Clinical Immunobiology and Transplantation, Montreal, Quebec, Canada.
D015703:Antigens, CD / Q000097:blood; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D006968:Hypersensitivity, Delayed; D007165:Immunosuppression Therapy / Q000379:methods*; D016030:Kidney Transplantation / Q000276:immunology*; D016131:Lymphocyte Subsets / Q000276:immunology*; D016853:Muromonab-CD3 / Q000627:therapeutic use; D012882:Skin Tests
D015703:Antigens, CD; D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D016572:Cyclosporine